Topics:

Multiple sclerosis

Stratifying PML Risk in Multiple Sclerosis

Here's a study that helps guide your choices when you discover that patients who are doing well on Tysabri have positive JC virus titers.
 

FsdffsdFor people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability. - See more at: http://www.neurologytimes.com/multiple-sclerosis#sthash.Aq5cH0PQ.dpuf

MS and Cigarettes: Where There’s Smoke, There’s Disease Progression

For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.

- See more at: http://www.neurologytimes.com/multiple-sclerosis#sthash.P3SjVoYj.dpuf

For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.

- See more at: http://www.neurologytimes.com/multiple-sclerosis#sthash.P3SjVoYj.dpuf
For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability. - See more at: http://www.neurologytimes.com/multiple-sclerosis#sthash.Aq5cH0PQ.dpuf

Multiple sclerosis

This treatment may be superior to current treatment for patients with severe multiple sclerosis that is not responding well to standard treatments.

A new study indicates that infection with Helicobacter pylori might lower the risk of multiple sclerosis, at least in women. Pharmaceutical products could provide a novel means of treatment.

The risk of progressive multifocal leukoencephalopathy in patients receiving Tysabri for MS is a concern about this otherwise extremely effective therapy.

HDIT/HCT could induce sustained remission and neurological improvements in patients with multiple sclerosis.

No evidence of disease activity (NEDA) is a new concept developing in MS. The field is beginning to ask how well the new treatments are doing and whether can we ultimately shut down the disease.

What happens before the demyelinating lesions of MS appear? Does smoking confer protection against Parkinson disease? How is NMDA receptor-associated disease reversed? Here are 4 fine papers from 2014 that set out to answer these questions.

Get to the root of the latest research findings on nervous system disorders and test your brainpower with this quick 5-question quiz.

Pages

Subscribe to Multiple sclerosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.